• December 31, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (EST) on Wednesday, Feb. 11, 2015. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Paul Herendeen will review fourth quarter and full year 2014 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetismore...
  • December 17, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2015 dividend payable to holders of the company’s common stock of $0.083 per share, an increase of 15% from the quarterly dividend rate paid in 2014. The dividend is to be paid on Tuesday, Mar. 3, 2015, to holders of record on Thursday, Jan. 22, 2015. “In 2014, we continued to demonstrate the strength of our business model and deliver our long-term valuemore...
  • December 17, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 14, in San Francisco, Calif. Juan Ramón Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 1:00 p.m. EST (10:00 a.m. PST). Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://more...
  • December 2, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Animal & Dental Health Summit on Thursday, Dec. 11, in Boston, Mass. Paul Herendeen, Executive Vice President and Chief Financial Officer, and Clint Lewis, Executive Vice President and President, U.S. Operations, will represent the company and respond to questions from analysts. They are scheduled to present at 12:30 p.m. EST. The meeting is not scheduledmore...
  • November 18, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS), the world’s leading animal health company, today hosted its first-ever Investor Day, discussing with investors and analysts the company’s leadership position in the animal health industry and the strategy and initiatives underway that will drive growth and create value for shareholders. The company also provided full-year 2015 financial guidance and outlined its longer term financial goals through 2017. “more...
  • November 18, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), the world’s leading animal health company, today announced that its Board of Directors has authorized a $500 million share repurchase program as part of its capital allocation plans. The shares are expected to be repurchased at the discretion of management, depending on market conditions and business needs. The authorization allows for repurchases to be conducted through open market or privately negotiated transactionsmore...
  • November 17, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million. Abbott Animal Health is a companion animal health business focused on the veterinary surgical suite. This acquisition will strengthen Zoetis’ companion animal product portfolio and expand its diagnostics business as more pets are being treated for pain and serious illnesses, such as cancer and diabetesmore...
  • November 14, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced that its Board of Directors has adopted a one-year shareholder rights plan (the “Plan”) and declared a dividend distribution of one preferred share purchase right (a “Right”) for each outstanding share of the Company’s common stock. The Plan will automatically expire on November 16, 2015, unless the Rights are earlier redeemed, exchanged or terminated. The Plan is intended to protect shareholdersmore...
  • November 5, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, Dec. 2, in New York, N.Y. Paul Herendeen, Executive Vice President and Chief Financial Officer, and Dr. Catherine Knupp, Executive Vice President and President, Research and Development, will represent the company and respond to questions from analysts. They are scheduled to present at 8:30 a.m. EST. Investors and other interestedmore...
  • November 4, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2014. The company reported revenue of $1.2 billion for the third quarter of 2014, an increase of 10% from the third quarter of 2013. Revenue reflected an operational2 increase of 10%, with foreign currency having no material impact on revenue growth this quarter. Net income for the third quarter of 2014 was $166 million, or $0.33 per dilutedmore...